Compressed Sensing Technology Accelerated 3D-FLAIR MRI Sequence for Endolymphatic Hydrops at 3T

Area of Science:

• Radiology
• Medical Imaging
• Neurotology

Background:

• 3D-FLAIR MRI is crucial for diagnosing endolymphatic hydrops (EH) in Meniere disease (MD).
• Clinical use of 3D-FLAIR is limited by its lengthy acquisition time.

Purpose of the Study:

• To evaluate the efficacy of 3D-FLAIR combined with compressed sensing (3D-FLAIR-CS) technology.
• To determine if 3D-FLAIR-CS can shorten scan times while preserving image quality and diagnostic performance for EH detection.

Main Methods:

• Prospective study of 50 patients with unilateral definite Meniere disease.
• Comparison of traditional 3D-FLAIR (10 min 35 sec) with 3D-FLAIR-CS (5 min 25 sec) at 3T MRI.
• Assessment of image quality using quantitative (CNR, SNR, SIR) and qualitative metrics; diagnostic efficacy compared using chi-square tests.

Main Results:

• No significant differences in image quality or diagnostic efficacy for EH between 3D-FLAIR and 3D-FLAIR-CS (P > .05).
• Quantitative image quality metrics (CNR, SNR, SIR) showed no statistically significant differences between the two sequences.
• Both sequences demonstrated excellent intra- and interobserver agreement (kappa > 0.80).

Conclusions:

• 3D-FLAIR-CS reduces acquisition time by about 50% compared to traditional 3D-FLAIR.
• Image quality and diagnostic efficacy for assessing endolymphatic hydrops remain equivalent between the two methods.
• 3D-FLAIR-CS offers a more time-efficient alternative for MRI in Meniere disease.